BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 27081022)

  • 1. Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
    Rommel KP; von Roeder M; Latuscynski K; Oberueck C; Blazek S; Fengler K; Besler C; Sandri M; Lücke C; Gutberlet M; Linke A; Schuler G; Lurz P
    J Am Coll Cardiol; 2016 Apr; 67(15):1815-1825. PubMed ID: 27081022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction: correlation of global longitudinal strain with invasive diastolic functional indices.
    Ito H; Ishida M; Makino W; Goto Y; Ichikawa Y; Kitagawa K; Omori T; Dohi K; Ito M; Sakuma H
    J Cardiovasc Magn Reson; 2020 Jun; 22(1):42. PubMed ID: 32498688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
    Su MY; Lin LY; Tseng YH; Chang CC; Wu CK; Lin JL; Tseng WY
    JACC Cardiovasc Imaging; 2014 Oct; 7(10):991-7. PubMed ID: 25240451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Load-Independent Systolic and Diastolic Right Ventricular Function in Heart Failure With Preserved Ejection Fraction as Assessed by Resting and Handgrip Exercise Pressure-Volume Loops.
    Rommel KP; von Roeder M; Oberueck C; Latuscynski K; Besler C; Blazek S; Stiermaier T; Fengler K; Adams V; Sandri M; Linke A; Schuler G; Thiele H; Lurz P
    Circ Heart Fail; 2018 Feb; 11(2):e004121. PubMed ID: 29449367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial Native T
    Omori T; Nakamori S; Fujimoto N; Ishida M; Kitagawa K; Ichikawa Y; Kumagai N; Kurita T; Imanaka-Yoshida K; Hiroe M; Sakuma H; Ito M; Dohi K
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2117-2128. PubMed ID: 32771571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Left Atrial Function on Exercise Capacity and Left Ventricular Function in Patients With Heart Failure and Preserved Ejection Fraction.
    von Roeder M; Rommel KP; Kowallick JT; Blazek S; Besler C; Fengler K; Lotz J; Hasenfuß G; Lücke C; Gutberlet M; Schuler G; Schuster A; Lurz P
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28360259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
    Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial Fibrosis, Functional Status, and Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Cardiac Magnetic Resonance Imaging Study.
    Duca F; Kammerlander AA; Zotter-Tufaro C; Aschauer S; Schwaiger ML; Marzluf BA; Bonderman D; Mascherbauer J
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27974408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiogram-less, free-breathing myocardial extracellular volume fraction mapping in small animals at high heart rates using motion-resolved cardiovascular magnetic reesonance multitasking: a feasibility study in a heart failure with preserved ejection fraction rat model.
    Han P; Zhang R; Wagner S; Xie Y; Cingolani E; Marban E; Christodoulou AG; Li D
    J Cardiovasc Magn Reson; 2021 Feb; 23(1):8. PubMed ID: 33568177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of elevated right ventricular extracellular volume in pulmonary hypertension using Accelerated and Navigator-Gated Look-Locker Imaging for Cardiac T1 Estimation (ANGIE) cardiovascular magnetic resonance.
    Mehta BB; Auger DA; Gonzalez JA; Workman V; Chen X; Chow K; Stump CJ; Mazimba S; Kennedy JL; Gay E; Salerno M; Kramer CM; Epstein FH; Bilchick KC
    J Cardiovasc Magn Reson; 2015 Dec; 17():110. PubMed ID: 26692265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness.
    Ellims AH; Shaw JA; Stub D; Iles LM; Hare JL; Slavin GS; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2014 Mar; 63(11):1112-8. PubMed ID: 24518490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between diffuse fibrosis assessed by CMR and depressed myocardial strain in different stages of heart failure.
    Zhang Y; Zhang X; Wang Y; Hu X; Wang B; Yang J; Zhao X; Zhang L
    Eur J Radiol; 2023 Jul; 164():110848. PubMed ID: 37156180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the intravascular and interstitial compartments of remodeled myocardium in heart failure patients with preserved and reduced ejection fraction: a CMR study.
    Masci PG; Pavon AG; Berchier G; Schwitter J
    BMC Med Imaging; 2019 Jan; 19(1):1. PubMed ID: 30611240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of elevated left ventricular end diastolic pressure in patients with preserved ejection fraction using cardiac magnetic resonance.
    Gao C; Tao Y; Pan J; Shen C; Zhang J; Xia Z; Wan Q; Wu H; Gao Y; Shen H; Lu Z; Wei M
    Eur Radiol; 2019 May; 29(5):2360-2368. PubMed ID: 30631923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive Echocardiographic and Cardiac Magnetic Resonance Evaluation Differentiates Among Heart Failure With Preserved Ejection Fraction Patients, Hypertensive Patients, and Healthy Control Subjects.
    Mordi IR; Singh S; Rudd A; Srinivasan J; Frenneaux M; Tzemos N; Dawson DK
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):577-585. PubMed ID: 28823736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of Heart Failure With Preserved Ejection Fraction Across the Range of Left Ventricular Ejection Fraction.
    Rosch S; Kresoja KP; Besler C; Fengler K; Schöber AR; von Roeder M; Lücke C; Gutberlet M; Klingel K; Thiele H; Rommel KP; Lurz P
    Circulation; 2022 Aug; 146(7):506-518. PubMed ID: 35862208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
    Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.